hemodynamic – Page 7 – Communicable Diseases Research

Non‐invasive hemodynamic profile of early COVID‐19 infection

Original Research

Published on 2020-10-282022-10-28
Journal: Physiological Reports [Category] Coronavirus, MERS, SARS,

Massive Pulmonary Embolism Complicating Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report

Case Report

Published on 2020-10-272022-10-31
Journal: Case Reports in Critical Care [Category] COVID-19,

[키워드] acute pulmonary embolism Administered afebrile Computed tomography cough Course COVID-19 COVID-19 patient CTPA Diagnosis discharged ECG elevated Embolism etiology Evidence feasible febrile had no healthy heart failure help hemodynamic hemodynamic instability hemodynamic status highlight home quarantine hypercoagulable hypoxic respiratory failure imperative Initially intubation management massive mechanical ventilatory support myalgia Nasopharyngeal swab Oxygenation Pneumonia positive Prognosis pulmonary pulmonary angiography report Respiratory failure risk RT-PCR SARS-COV-2 infection Severe COVID-19 pneumonia Shortness of breath significantly sore throat Swab Tachycardia the patient therapy TTE vasopressor support was obtained worsening
[DOI] 10.1155/2020/8875330 PMC 바로가기 [Article Type] Case Report

Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia

코비드19-폐렴 환자의 고유량 21% 산소 에어로졸에서 아데노신의 치료 효과

Research Article

Published on 2020-10-082022-08-13
Journal: PLoS ONE [Category] Biochemistry, COVID-19, MERS, SARS,

[키워드] 24 hour 24 hours active treatments adenosine agonist Analysis ARDS bronchospasm change clinical trials control group controlled clinical trials death demonstrated Effect enrolled experimental group feature hemodynamic historical control Hospitalized Infection Inflammatory inflammatory lung disease Inhaled interstitial lack lung Lung disease Lung inflammation mice Mitigation moderate outcome oxygen oxygenated PaO Patient patients treated preclinical studies preclinical study radiological receive receiving receptor recorded reported Result SARS-CoV-2 RNA SARS-CoV2 infection severe lung inflammation severity significant increase syndrome the disease therapeutic effect Treatment Trigger Ventilation were recorded
[DOI] 10.1371/journal.pone.0239692 PMC 바로가기 [Article Type] Research Article

Indications for and Findings on Transthoracic Echocardiography in COVID-19

Research article

Published on 2020-10-012022-10-05
Journal: Journal of the American Society of Echocardiograph [Category] SARS, 바이오마커,

[키워드] abnormality acute respiratory syndrome Cardiomyopathy cardiovascular complication cardiovascular event Care changed clinical Clinical data Clinical management coronavirus disease Coronavirus-2 COVID-19 demographic Diagnosis diagnostic disease echocardiograms echocardiographic finding echocardiography eight Ejection fraction Evidence finding hemodynamic hemodynamic instability Hospitalization hospitalized patient indication individual LVEF management New York City Patient patients polymerase chain positive positive result preserved reduced reductions in Result Retrospective analysis selected Spearman rank correlation TTE ventricular was performed with COVID-19
[DOI] 10.1016/j.echo.2020.06.009 [Article Type] Research article

Acute Guillain-Barré polyradiculoneuritis indicative of COVID-19 infection: a case report

Case Report

Published on 2020-08-272022-10-28
Journal: The Pan African Medical Journal [Category] COVID-19, MERS, SARS,

High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial

COVID-19에 따른 급성 호흡곤란 증후군에 대한 고용량 덱사메타손 치료: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2020-08-262022-08-13
Journal: Trials [Category] MERS, 임상,

[키워드] 1:1 active cancer acute respiratory distress acute respiratory distress syndrome Adult patients advance directives Advanced cancer age alpha error anticipated approved ARDS assessment assigned bilateral pulmonary infiltrates Blinding block breast-feeding Buenos Aires capture cardiac disease CEMIC clinical clinical trial code Complete concealed Confirmed COVID-19 COVID-19, Dexamethasone, Acute Respiratory Distress Syndrome, Randomised controlled trial, protocol, Steroids delirium develop Dexamethasone diagnosis of SARS-CoV-2 directive discharge disease dissemination do not resuscitate dose Effectiveness element End-Expiratory Pressure evaluate exclusion criteria Expiratory Pressure explained failure followed by Frequency glucocorticoid Glucocorticoids group hemodynamic High dose HIV infection hypoxemic Hypoxemic respiratory failure ICU Immunosuppression Immunosuppressive agents include inclusion criteria Infection Informed consent intensive care unit International legal guardian Length less Life expectancy local Ethics Committee mechanical ventilation Mortality multicenter muscle weakness Nosocomial infection Nosocomial infections number objective open open label open trial other disease other diseases outcome Palliative care PaO parallel group participant Participation Patient Patient care platform Pneumonia Positive end-expiratory pressure power power of 80% Prednisone pressure Prone position protocol R language random randomised randomised controlled trial randomization Randomized randomized clinical trial receive recruitment Registered renal renal disease respiratory respiratory distress Respiratory distress syndrome Respiratory failure resuscitate order RT-PCR Sample size SARS-COV-2 infection SARS-CoV-2 pneumonia secondary Secondary outcomes secondary to sequence Sequential Organ Failure Assessment severe immunosuppression SOFA Standard deviation status Stratified randomization Study protocol subject Support syndrome table terminal Terminal disease title Treatment treatment groups Trial Trial registration two-tailed alpha error Variation ventilator ventilator-free day Ventilator-free days ventilatory Version viral shedding weakness website women
[DOI] 10.1186/s13063-020-04646-y PMC 바로가기 [Article Type] Letter

Nutrition of the COVID-19 patient in the intensive care unit (ICU): a practical guidance

Review

Published on 2020-07-192022-11-01
Journal: Critical Care [Category] COVID-19,

Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol

Letter

Published on 2020-06-262022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] 1:1 24 hour Administered airway allocation concealment Alpha ambient analysed aneurysms Anticoagulant treatment anticoagulation antiplatelet Arm arterial assigned Atrial fibrillation bleeding bleeding event block size Blood BMI Body Breastfeeding breath calculated Cancer clinical clinically Coagulopathy Concomitant conjunctival Continuous contributed Control control group Controlled trial corpus COVID-19 COVID19 criteria Critical D-dimer D-dimer level Day death defined detect diagnostic discharged disease severity dissemination dosage dose effective Efficacy and safety element enoxaparin Epistaxis EudraCT event events expected fibrinogen level gingival bleeding group Haemoglobin haemoptysis health-care hematemesis hematoma hemodynamic heparin High dose high risk history hospital discharge Hospital stay hospitalized patient hypersensitivity Hypothesis IL-6 Impaired impairing improvement IMV In-hospital indication initiated Inpatient INR internal Intervention intervention group Intra-articular intramuscular invasive Invasive mechanical ventilation involved Italian Italy laboratory parameter LMWH low dose low-molecular weight heparin macroscopic Major major bleeding management Mechanical mechanical ventilation medical intervention Medicine Modena NIV Non-invasive number objective occur Occurrence open label ophthalmic oral anticoagulant outcome oxygen paO2/fiO2 parallel group participant pathology Patient performed Pharyngeal swab plasma Platelet Pneumonia positive pregnancy test Presence pressure Primary outcome prophylactic dose prosthetic protocol random randomisation randomised randomised controlled randomised controlled trial randomization Rate receiving recorded recruited Rectal Bleeding reduce reduction in Registered renal function reported required respiratory risk risk of death Sample size SARS-CoV-2 secondary secure Severe COVID-19 pneumonia severe disease significantly Spontaneous standard oxygen therapy Stata status stratified stroke study drug Study protocol subcutaneously surgical susceptible symptomatic syndrome therapeutic dose therapy thrombocytopenia time transfusion Treatment unfractionated heparin unit Vascular venipuncture Venous Thromboembolism web-based system website weight Withdrawal worsening
[DOI] 10.1186/s13063-020-04475-z PMC 바로가기 [Article Type] Letter

Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients

Review

Published on 2020-06-152022-10-28
Journal: Aging (Albany NY) [Category] COVID-19,

[키워드] ACE2 acute respiratory syndrome Admission affected age aggravate angiotensin-converting enzyme 2 Anxiety Biomarker blood pressure Central nervous system chronic disease Comorbidity coronavirus coronavirus disease cough COVID-19 COVID-19 patient diabetes distress downregulation endothelial function enzyme expression Fever first symptoms fraction hemodynamic Hemorrhagic Stroke host cell surface human infectious disease hypertension immune dysfunction Immunity impairing Infection mechanism mechanisms morbidity Mortality Neurological symptom parameter Pathogenesis Patient Potential receptor report risk risk factor SARS-CoV-2 spike glycoprotein Stress stroke Symptom systemic inflammatory viral entry while
[DOI] 10.18632/aging.103335 PMC 바로가기 [Article Type] Review

Feedback to Prepare EMS Teams to Manage Infected Patients with COVID-19: A Case Series

Case Report

Published on 2020-06-082022-10-29
Journal: Prehospital and Disaster Medicine [Category] Coronavirus, MERS, SARS,